Life Scientist > Biotechnology

Gene therapy trial results in significant vision improvements

17 September, 2024

The vision of people with a rare inherited condition that causes them to lose much of their sight early in childhood was anywhere from 100 to 10,000 times better after they received gene therapy.


Non-hormonal drug treats hot flashes in menopausal women

06 September, 2024

The investigational drug elinzanetant has been found to reduce the frequency and severity of hot flashes associated with menopause while improving women's sleep and quality of life.


Children's heart implant expands when activated by light

29 August, 2024

Researchers have designed a shunt that expands when activated by light, which could reduce the number of open-chest surgeries required by children with congenital heart defects.


Malaria parasites tricked into ingesting drugs

28 August, 2024

Scientists have developed a 'Trojan horse' method that tricks malaria parasites into ingesting a fatal dose of drugs by exploiting the parasite's need for cholesterol to survive.


Two-step flu vaccine strategy shows promise in pigs

22 August, 2024

A two-step flu vaccination strategy that pairs intramuscular injection of a viral vectored flu vaccine with nasal spray administration of a novel attenuated live flu virus appears to be safe and effective in pigs.


Improving autoimmune conditions in Down syndrome patients

21 August, 2024

A first-in-kind clinical trial has tested the safety and efficacy of a JAK inhibitor in decreasing the burden of autoimmune skin conditions in people with Down syndrome.


Iron-binding drug could be used to treat ovarian cancer

20 August, 2024

Iron is essential for multiple cellular processes, so actively multiplying cancer cells often need larger amounts of it than normal cells.


First-in-human implantation of BiVACOR's total artificial heart

30 July, 2024

The first-in-human implantation was performed in a critically ill 57-year-old man who was in cardiogenic shock and awaiting a heart transplant.


Sodium ascorbate rapidly reverses sepsis-induced brain injury

23 July, 2024

A megadose of sodium ascorbate can turn around sepsis-induced low oxygen levels, low blood flow and high temperature within the brain's frontal cortex.


New MDMA variants could enable safe psychotherapeutic use

11 July, 2024

The newly developed MDMA variants have been modified in such a way that the positive effects are retained and the negative effects are reduced.


Treating rare skin diseases with transplants

05 July, 2024

Researchers at Nagoya University have treated the skin diseases epidermolytic ichthyosis (EI) and ichthyosis with confetti (IWC) by transplanting genetically healthy skin to inflamed areas.


New therapy could treat hypertension-induced organ damage

28 June, 2024

Compound17b (Cmpd17b) is a potent therapeutic agent capable of safeguarding against the ravages of high blood pressure on vital organs.


Nanoparticle could help map, treat children's brain cancer

26 June, 2024

The nanoparticle could be used for delivering small interfering RNA (siRNA) directly to the brain cancer site, slowing tumour growth without causing signs of toxicity.


Nanodroplet drug carriers triggered by ultrasound

24 June, 2024

By releasing the drug at exactly the desired spot in the body, this allows the total dose to be dramatically lower, which should minimise side effects.


Drug trial results show lung cancer patients are living longer

21 June, 2024

Five years after treatment, 60% of patients treated with lorlatinib remained alive and without disease progression; this compared to just 8% for patients who received crizotinib.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd